Alpha 2.0
Login Register
» Authors » Hetty Jolink

Hetty Jolink

Explore the profile of Hetty Jolink including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 142
Followers 0
Related Specialties
Allergy & Immunology
Infectious Diseases
General Medicine
Top 10 Co-Authors
Jaap T van Dissel
Marloes Grobben
J H Frederik Falkenburg
Marit J van Gils
Corine H GeurtsvanKessel
Rory D de Vries
Virgil A S H Dalm
Mirjam H M Heemskerk
Judith Potjewijd
Abraham Rutgers
Published In
Front Immunol
Eur J Clin Pharmacol
Haematologica
Med Mycol
J Proteome Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies
Gijze S, Wasynczuk A, van Leeuwen L, Grobben M, van Gils M, Nouta J, et al.
J Proteome Res . 2024 Nov; 23(12):5600-5605. PMID: 39537390
Antibodies have a key role in the immune system, making their characterization essential to biomedical, biopharmaceutical, and clinical research questions. Antibody effector functions are mainly controlled by quantity, subclass, and...
2.
Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant
de Gier M, Pico-Knijnenburg I, van Ostaijen-Ten Dam M, Berghuis D, Smiers F, van Beek A, et al.
Front Immunol . 2024 Jul; 15:1397567. PMID: 39044816
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for various hematological, immunological and metabolic diseases, replacing the patient's hematopoietic system with donor-derived healthy hematopoietic stem cells. HSCT can...
3.
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
van Leeuwen L, Grobben M, GeurtsvanKessel C, Ellerbroek P, de Bree G, Potjewijd J, et al.
Front Immunol . 2024 May; 15:1390022. PMID: 38698851
Purpose: Previous studies have demonstrated that the majority of patients with an inborn error of immunity (IEI) develop a spike (S)-specific IgG antibody and T-cell response after two doses of...
4.
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
van Leeuwen L, Grobben M, GeurtsvanKessel C, Ellerbroek P, de Bree G, Potjewijd J, et al.
J Clin Immunol . 2023 May; 43(6):1104-1117. PMID: 37231290
Purpose: Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective long-term protection against COVID-19 is therefore of great importance in these patients,...
5.
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
van Leeuwen L, GeurtsvanKessel C, Ellerbroek P, de Bree G, Potjewijd J, Rutgers A, et al.
J Allergy Clin Immunol . 2022 Apr; 149(6):1949-1957. PMID: 35421449
Background: Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of great importance in this group, but...
6.
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance
van de Peppel R, van Grootveld R, Hendriks B, van Paassen J, Bernards S, Jolink H, et al.
Med Mycol . 2021 Dec; 60(1). PMID: 34878121
Lay Summary: Due to resistance of Aspergillus against triazoles, combination therapy with liposomal amphotericin B (LAmB) is applied more often as primary therapy against invasive aspergillosis. This study presents the...
7.
B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review
Diks A, Overduin L, van Leenen L, Slobbe L, Jolink H, Visser L, et al.
Front Immunol . 2021 Sep; 12:690328. PMID: 34557188
Vaccination is the most effective measure to prevent infections in the general population. Its efficiency strongly depends on the function and composition of the immune system. If the immune system...
8.
Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells
Jolink H, de Boer R, Hombrink P, Jonkers R, van Dissel J, Falkenburg J, et al.
J Infect . 2016 Nov; 74(1):81-88. PMID: 27838522
Objectives: To compare the cytokine profiles of Aspergillus-specific CD4+ T-cells in peripheral blood and in the lung. To investigate the Thelper phenotype at the primary location of A. fumigatus exposure....
9.
Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis
Jolink H, Hagedoorn R, Lagendijk E, Drijfhout J, van Dissel J, Falkenburg J, et al.
Haematologica . 2014 Apr; 99(7):1255-63. PMID: 24747947
After allogeneic stem cell transplantation patients are at risk of invasive aspergillosis, especially during the period of neutropenia. Recent data suggest that impaired T-cell immune reconstitution after transplantation plays an...
10.
Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals
Jolink H, Meijssen I, Hagedoorn R, Arentshorst M, Drijfhout J, Mulder A, et al.
J Infect Dis . 2013 May; 208(5):847-56. PMID: 23698813
Invasive aspergillosis is a serious infectious complication after allogeneic stem cell transplantation. One of the strategies to improve the management of aspergillosis is the adoptive transfer of antigen-specific T cells,...